BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36374432)

  • 1. Predictors of response of rituximab in rheumatoid arthritis by weighted gene co-expression network analysis.
    Zhang S; Li P; Wu P; Yang L; Liu X; Liu J; Zhang Y; Zeng J
    Clin Rheumatol; 2023 Feb; 42(2):529-538. PubMed ID: 36374432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying hub circadian rhythm biomarkers and immune cell infiltration in rheumatoid arthritis.
    Wen P; Ma T; Zhang B; Hao L; Wang Y; Guo J; Song W; Wang J; Zhang Y
    Front Immunol; 2022; 13():1004883. PubMed ID: 36238290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interferon type I signature towards prediction of non-response to rituximab in rheumatoid arthritis patients.
    Raterman HG; Vosslamber S; de Ridder S; Nurmohamed MT; Lems WF; Boers M; van de Wiel M; Dijkmans BA; Verweij CL; Voskuyl AE
    Arthritis Res Ther; 2012 Apr; 14(2):R95. PubMed ID: 22540992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying key genes in rheumatoid arthritis by weighted gene co-expression network analysis.
    Ma C; Lv Q; Teng S; Yu Y; Niu K; Yi C
    Int J Rheum Dis; 2017 Aug; 20(8):971-979. PubMed ID: 28440025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Machine learning to identify immune-related biomarkers of rheumatoid arthritis based on WGCNA network.
    Chen Y; Liao R; Yao Y; Wang Q; Fu L
    Clin Rheumatol; 2022 Apr; 41(4):1057-1068. PubMed ID: 34767108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug screening and identification of key candidate genes and pathways of rheumatoid arthritis.
    Shi YQ; Qi WF; Kong CY
    Mol Med Rep; 2020 Aug; 22(2):986-996. PubMed ID: 32468016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fetuin-A and thyroxin binding globulin predict rituximab response in rheumatoid arthritis patients with insufficient response to anti-TNFα.
    Nguyen MVC; Courtier A; Adrait A; Defendi F; Couté Y; Baillet A; Guigue L; Gottenberg JE; Dumestre-Pérard C; Brun V; Gaudin P
    Clin Rheumatol; 2020 Sep; 39(9):2553-2562. PubMed ID: 32212002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of whole-blood transcriptomic profiling to highlight several pathophysiologic pathways associated with response to rituximab in patients with rheumatoid arthritis: data from a randomized, controlled, open-label trial.
    Sellam J; Marion-Thore S; Dumont F; Jacques S; Garchon HJ; Rouanet S; Taoufik Y; Hendel-Chavez H; Sibilia J; Tebib J; Le Loët X; Combe B; Dougados M; Mariette X; Chiocchia G
    Arthritis Rheumatol; 2014 Aug; 66(8):2015-25. PubMed ID: 24756903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Identification and validation of novel biomarkers for cold-dampness syndrome of rheumatoid arthritis based on integration of multiple bioinformatics methods].
    Li T; Chen WJ; Zhang YQ; Liu W; Lin N; Liu XT
    Zhongguo Zhong Yao Za Zhi; 2023 Dec; 48(24):6721-6729. PubMed ID: 38212032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A combination of cellular biomarkers predicts failure to respond to rituximab in rheumatoid arthritis: a 24-week observational study.
    Stradner MH; Dejaco C; Brickmann K; Graninger WB; Brezinschek HP
    Arthritis Res Ther; 2016 Aug; 18(1):190. PubMed ID: 27558631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Critical Biomarkers and Immune Infiltration in Rheumatoid Arthritis Based on WGCNA and LASSO Algorithm.
    Jiang F; Zhou H; Shen H
    Front Immunol; 2022; 13():925695. PubMed ID: 35844557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the susceptible genes and mechanism underlying the comorbid presence of coronary artery disease and rheumatoid arthritis: a network modularization analysis.
    Zhang S; Niu Q; Tong L; Liu S; Wang P; Xu H; Li B; Zhang H
    BMC Genomics; 2023 Jul; 24(1):411. PubMed ID: 37474895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of candidate genes for rituximab response in rheumatoid arthritis patients by microarray expression profiling in blood cells.
    Julià A; Barceló M; Erra A; Palacio C; Marsal S
    Pharmacogenomics; 2009 Oct; 10(10):1697-708. PubMed ID: 19842941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comprehensive review of rituximab therapy in rheumatoid arthritis patients.
    Tavakolpour S; Alesaeidi S; Darvishi M; GhasemiAdl M; Darabi-Monadi S; Akhlaghdoust M; Elikaei Behjati S; Jafarieh A
    Clin Rheumatol; 2019 Nov; 38(11):2977-2994. PubMed ID: 31367943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of diagnostic biomarkers and immuno-infiltration analysis for rheumatoid arthritis based on biological information and WGCNA.
    Zhang Y; Yang QY; Yang LS; Zhang J; Zhang K; Liu Y; Xu XD; Yang XY; Wang J; Yan B
    Eur Rev Med Pharmacol Sci; 2023 Aug; 27(16):7470-7484. PubMed ID: 37667923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of diagnostic genes and vital microRNAs involved in rheumatoid arthritis: based on data mining and experimental verification.
    Ren C; Li M; Zheng Y; Wu F; Du W; Quan R
    PeerJ; 2021; 9():e11427. PubMed ID: 34040897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of rituximab in resistant palindromic rheumatism: first report in literature.
    Raghavan P; Sreenath S; Cherian S; Shenoy PD
    Clin Rheumatol; 2019 Sep; 38(9):2399-2402. PubMed ID: 31076945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Derlin-1, as a Potential Early Predictive Biomarker for Nonresponse to Infliximab Treatment in Rheumatoid Arthritis, Is Related to Autophagy.
    Cai Y; Xu K; Aihaiti Y; Li Z; Yuan Q; Xu J; Zheng H; Yang M; Wang B; Yang Y; Yang Y; Xu P
    Front Immunol; 2021; 12():795912. PubMed ID: 35046954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High anti-CCP antibody titres predict good response to rituximab in patients with active rheumatoid arthritis.
    Gardette A; Ottaviani S; Tubach F; Roy C; Nicaise-Roland P; Palazzo E; Gill G; Meyer O; Dieudé P
    Joint Bone Spine; 2014 Oct; 81(5):416-20. PubMed ID: 24998790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of biosimilar CT-P10 and innovator rituximab in patients with rheumatoid arthritis: a randomized controlled Phase 3 trial.
    Park W; Božić-Majstorović L; Milakovic D; Berrocal Kasay A; El-Khouri EC; Irazoque-Palazuelos F; Molina FFC; Shesternya P; Miranda P; Medina-Rodriguez FG; Wiland P; Jeka S; Chavez-Corrales J; Garmish O; Linde T; Rekalov D; Hrycaj P; Krause A; Fomina N; Piura O; Abello-Banfi M; Suh CH; Shim SC; Lee SJ; Lee SY; Kim SH; Yoo DH
    MAbs; 2018; 10(6):934-943. PubMed ID: 30010481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.